Kidney Disease News and Research

RSS

3D eye scans could help to track the progression of kidney disease

3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests.

5 Dec 2023

Leading public health groups urge high-risk patients to get flu shot

During National Influenza Vaccination Week (December 4-8, 2023), leading public health organizations are encouraging everyone to get a flu shot if they have not already done so.

4 Dec 2023

Study identifies increased burden of chronic health conditions in LGB cancer survivors

Lesbian, gay, and bisexual (LGB) adolescents and young adult cancer survivors in the United States are more likely to report experiencing chronic health conditions than their heterosexual peers with a history of cancer as well as their LGB peers without a past cancer diagnosis.

4 Dec 2023

New guideline emphasizes prevention, early rhythm control for atrial fibrillation

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

30 Nov 2023

Clinical trial reveals dapagliflozin's impact on heart failure and type 2 diabetes management

Researchers conducted a clinical trial on the effects of dapagliflozin on the urinary albumin-to-creatinine ratio (UACR) in patients with heart failure (HF) and type 2 diabetes mellitus (T2D).

29 Nov 2023

Social support needed to reduce the barriers in accessing cardiac rehabilitation

Noted experts in cardiovascular rehabilitation attending the Third Jim Pattison-Mazankowski Alberta Heart Institute Cardiac Rehabilitation Symposium (Banff, April 21-23, 2023) observed that although cardiac rehabilitation benefits diverse groups of patients and affords the most cost-effective prevention for recurrent events, it is grossly underutilized globally.

28 Nov 2023

Study challenges health benefits of artificially sweetened beverages, links to increased health risks

An umbrella review in Advances in Nutrition, examining previous systematic reviews and meta-analyses, reveals that regular consumption of artificially sweetened beverages (ASBs) is associated with increased risks of obesity, all-cause mortality, hypertension, type 2 diabetes, and cardiovascular disease, challenging the perception of ASBs as a healthier alternative to sugar-sweetened beverages.

15 Nov 2023

Facing financial ruin as costs soar for elder care

Margaret Newcomb, 69, a retired French teacher, is desperately trying to protect her retirement savings by caring for her 82-year-old husband, who has severe dementia, at home in Seattle.

14 Nov 2023

Study shows environment's pivotal role in healthy aging and disease prevention

Study explores new geroscience tools for studying the impact of environmental factors on aging, aiming to delay age-related diseases and disabilities. It highlights how non-genetic factors, like environmental toxins and socio-economic conditions, significantly influence aging and health outcomes.

13 Nov 2023

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

An intensive three-year intervention to lower the top blood pressure number to less than 120 mm Hg was more effective at preventing death, heart attack, stroke and other cardiovascular events in adults at high risk for cardiovascular disease, compared to the standard treatment target of under 140 mm Hg, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have had a heart attack and have anemia may reduce the risk of a reoccurrence and improve survival rates.

12 Nov 2023

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

A new calculator estimates a person's risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney and metabolic health for the first time, according to a new American Heart Association Scientific Statement published today in the Association's flagship journal Circulation.

10 Nov 2023

Yabing Chen receives NIH grants to advance vascular disease research

Yabing Chen, Ph.D., has been awarded two National Institutes of Health grants totaling more than $5 million to further her research into vascular diseases ranging from hardening of the arteries to dementia.

6 Nov 2023

Cutting-edge 'precision medicine' shows great potential to improve diabetes care

Cutting-edge “precision medicine” has great potential to advance the diagnosis, treatment and ultimate prevention of different forms of diabetes, an international coalition of scientists reports in a sweeping assessment of the state of the field around the world.

6 Nov 2023

Bayer Digital Health UKI introduces new technology to help type 2 diabetes patients manage kidney health

Bayer Digital Healthcare UKI has today announced the launch of its first digital patient support package, My Kidney Assistant, designed to provide type 2 diabetes (T2D) patients with the information and resources to help monitor and improve their kidney health.

6 Nov 2023

Sotagliflozin provides kidney and heart benefits in patients with diabetes and chronic kidney disease

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are medications that lower blood sugar levels among other effects, provide kidney- and heart-related benefits to patients with and without diabetes.

3 Nov 2023

Sparsentan may be a new treatment option for focal segmental glomerulosclerosis

Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and can lead to kidney failure.

3 Nov 2023

Racial and socioeconomic integration linked to lower health care expenditure disparities

Differences in health care expenditures between Black and white adults vary substantially with the local level of racial and economic integration, and tend to be low or nonexistent in highly integrated communities, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

3 Nov 2023

High-impact clinical trial results to be presented at ASN Kidney Week 2023

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5.

3 Nov 2023

New automated tool improves kidney disease screening in type 2 diabetes

Investigators have implemented an automated health maintenance tool created by the National Kidney Foundation into electronic medical records to prompt primary care physicians to screen for chronic kidney disease (CKD) in adult patients with type 2 diabetes.

2 Nov 2023

Kidney Disease News and Research

3D eye scans could help to track the progression of kidney disease

Leading public health groups urge high-risk patients to get flu shot

Study identifies increased burden of chronic health conditions in LGB cancer survivors

New guideline emphasizes prevention, early rhythm control for atrial fibrillation

Clinical trial reveals dapagliflozin's impact on heart failure and type 2 diabetes management

Social support needed to reduce the barriers in accessing cardiac rehabilitation

Study challenges health benefits of artificially sweetened beverages, links to increased health risks

Facing financial ruin as costs soar for elder care

Study shows environment's pivotal role in healthy aging and disease prevention

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

Yabing Chen receives NIH grants to advance vascular disease research

Cutting-edge 'precision medicine' shows great potential to improve diabetes care

Bayer Digital Health UKI introduces new technology to help type 2 diabetes patients manage kidney health

Sotagliflozin provides kidney and heart benefits in patients with diabetes and chronic kidney disease

Sparsentan may be a new treatment option for focal segmental glomerulosclerosis

Racial and socioeconomic integration linked to lower health care expenditure disparities

High-impact clinical trial results to be presented at ASN Kidney Week 2023

New automated tool improves kidney disease screening in type 2 diabetes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News